These alterations have been associated with a resistance to IGF1 stimulation, reflected in an attenuation of downstream AKT and ERK signaling as demonstrated in hippocampal brain slices from AD patients [24, 25]. The gene discussed is IGF1; the disease is Alzheimer disease.